Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Barbet, J' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 49 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Gruaz-Guyon, A; Janevik-Ivanovska, E; Raguin, O; De Labriolle-Vaylet, C; Barbet, J
      Radiolabeled bivalent haptens for tumor immunodetection and radioimmunotherapy

      QUARTERLY JOURNAL OF NUCLEAR MEDICINE
    2. Gestin, JF; Loussouarn, A; Bardies, M; Gautherot, E; Gruaz-Guyon, A; Sai-Maurel, C; Barbet, J; Curtet, C; Chatal, JF; Faivre-Chauvet, A
      Two-step targeting of xenografted colon carcinoma using a bispecific antibody and Re-188-labeled bivalent hapten: Biodistribution and dosimetry studies

      JOURNAL OF NUCLEAR MEDICINE
    3. Tran, A; Treluyer, JM; Rey, E; Barbet, J; Ferracci, G; d'Athis, P; Vincent, J; Pons, G
      Protective effect of stiripentol on acetaminophen-induced hepatotoxicity in rat

      TOXICOLOGY AND APPLIED PHARMACOLOGY
    4. de Labriolle-Vaylet, C; Cattan, P; Sarfati, E; Wioland, M; Billotey, C; Brocheriou, C; Rouvier, E; de Roquancourt, A; Rostene, W; Askienazy, S; Barbet, J; Milhaud, G; Gruaz-Guyon, A
      Successful surgical removal of occult metastases of medullary thyroid carcinoma recurrences with the help of immunoscintigraphy and radioimmunoguidedsurgery

      CLINICAL CANCER RESEARCH
    5. Karacay, H; McBride, WJ; Griffiths, GL; Sharkey, RM; Barbet, J; Hansen, HJ; Goldenberg, DM
      Experimental pretargeting studies of cancer with a humanized anti-CEA x murine anti-[In-DTPA] bispecific antibody construct and a Tc-99m-Re-188-labeled peptide

      BIOCONJUGATE CHEMISTRY
    6. de Boisferon, MH; Raguin, O; Dussaillant, M; Rostene, W; Barbet, J; Gruaz-Guyon, A
      Enhanced targeting specificity to tumor cells by simultaneous recognition of two antigens

      BIOCONJUGATE CHEMISTRY
    7. Hosono, MN; Hosono, M; Mishra, AK; Faivre-Chauvet, A; Gautherot, E; Barbet, J; Knapp, FF; Chatal, JF
      Rhenium-188-labeled anti-neural cell adhesion molecule antibodies with 2-iminothiolane modification for targeting small-cell lung cancer

      ANNALS OF NUCLEAR MEDICINE
    8. Gautherot, E; Rouvier, E; Daniel, L; Loucif, E; Bouhou, J; Manetti, C; Martin, M; Le Doussal, JM; Barbet, J
      Pretargeted radioimmunotherapy of human colorectal xenografts with bispecific antibody and I-131-labeled bivalent hapten

      JOURNAL OF NUCLEAR MEDICINE
    9. Pelegrin, A; Xavier, F; Barbet, J; Bartholeyns, J; Baty, D; Buchegger, F; Chatal, JF; Dubief, F; Guerreau, D; Gruaz-Guyon, A; Lamotte, D; Leserman, L; Mach, JP; Robert, B; Saccavini, JC; Teillaud, JL; Teulon, I
      Immunotargeting of tumors: state of the art and prospects in 2000

      BULLETIN DU CANCER
    10. Barbet, J; Kraeber-Bodere, F; Vuillez, JP; Gautherot, E; Rouvier, R; Chatal, JF
      Pretargeting with the Affinity Enhancement System for radioimmunotherapy

      CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
    11. Gautherot, E; Kraeber-Bodere, F; Daniel, L; Fiche, M; Rouvier, E; Sai-Maurel, C; Thedrez, P; Chatal, JF; Barbet, J
      Immunohistology of carcinoembryonic antigen (CEA)-expressing tumors grafted in nude mice after radioimmunotherapy with I-131-labeled bivalent hapten and anti-CEA x antihapten bispecific antibody

      CLINICAL CANCER RESEARCH
    12. Kraeber-Bodere, F; Faivre-Chauvet, A; Sai-Maurel, C; Campion, L; Fiche, M; Gautherot, E; Le Boterff, J; Barbet, J; Chatal, JF; Thedrez, P
      Toxicity and efficacy of radioimmunotherapy in carcinoembryonic antigen-producing medullary thyroid cancer xenograft: Comparison of iodine 131-labeled F(ab ')(2) and pretargeted bivalent hapten and evaluation of repeated injections

      CLINICAL CANCER RESEARCH
    13. Kraeber-Bodere, F; Bardet, S; Hoefnagel, CA; Vieira, MR; Vuillez, JP; Murat, A; Ferreira, TC; Bardies, M; Ferrer, L; Resche, I; Gautherot, E; Rouvier, E; Barbet, J; Chatal, JF
      Radioimmunotherapy in medullary thyroid cancer using bispecific antibody and iodine 131-labeled bivalent hapten: Preliminary results of a phase I/II clinical trial

      CLINICAL CANCER RESEARCH
    14. Vuillez, JP; Kraeber-Bodere, F; Moro, D; Bardies, M; Douillard, JY; Gautherot, E; Rouvier, E; Barbet, J; Garban, F; Moreau, P; Chatal, JF
      Radioimmunotherapy of small cell lung carcinoma with the two-step method using a bispecific anti-carcinoembryonic antigen/anti-diethylenetriaminepentaacetic acid (DTPA) antibody and iodine-131 Di-DTPA hapten: Results of a phase I/II trial

      CLINICAL CANCER RESEARCH
    15. Hosono, M; Hosono, MN; Kraeber-Bodere, F; Devys, A; Thedrez, P; Faivre-Chauvet, A; Gautherot, E; Barbet, J; Chatal, JF
      Two-step targeting and dosimetry for small cell lung cancer xenograft withanti-NCAM/antihistamine bispecific antibody and radioiodinated bivalent hapten

      JOURNAL OF NUCLEAR MEDICINE
    16. Kraeber-Bodere, F; Faivre-Chauvet, A; Sai-Maurel, C; Gautherot, E; Fiche, M; Campion, L; Le Boterff, J; Barbet, J; Chatal, JF; Thedrez, P
      Bispecific antibody and bivalent hapten radioimmunotherapy in CEA-producing medullary thyroid cancer xenograft

      JOURNAL OF NUCLEAR MEDICINE
    17. HOSONO M; HOSONO MN; KRAEBERBODERE F; DEVYS A; THEDREZ P; FICHE M; GAUTHEROT E; BARBET J; CHATAL JF
      BIODISTRIBUTION AND DOSIMETRIC STUDY IN MEDULLARY-THYROID CANCER XENOGRAFT USING BISPECIFIC ANTIBODY AND IODINE-125-LABELED BIVALENT HAPTEN

      The Journal of nuclear medicine
    18. BARBET J; PELTIER P; BARDET S; VUILLEZ JP; BACHELOT I; DENET S; OLIVIER P; LECCIA F; CORCUFF B; HUGLO D; PROYE C; ROUVIER E; MEYER P; CHATAL JF
      RADIOIMMUNODETECTION OF MEDULLARY-THYROID CARCINOMA USING IN-111 BIVALENT HAPTEN AND ANTI-CEA X ANTI-DTPA-INDIUM BISPECIFIC ANTIBODY

      The Journal of nuclear medicine
    19. VUILLEZ JP; MORO D; BODERE F; CURRAT C; MEYER P; BRAMBILLA C; CHATAL JF; BARBET J; FAGRET D
      RADIOIMMUNOTHERAPY OF SMALL-CELL LUNG-CARCINOMA WITH THE 2-STEP METHOD USING A BISPECIFIC ANTI-CEA ANTI-DTPA ANTIBODY AND THE I-131 DI-DTPAHAPTEN - PRELIMINARY-RESULTS/

      The Journal of nuclear medicine
    20. BODERE FK; BARDET S; VUILLEZ JP; BARDIES M; GAUTHEROT E; ROUVIER E; BARBET J; CHATAL JF
      PHASE I II TRIAL OF 2-STEP RADIOIMMUNOTHERAPY IN MEDULLARY-THYROID CANCER (MTC) USING BISPECIFIC ANTI-CEA/ANTI-DTPA-IN ANTIBODY AND IODINE-131-LABELED BIVALENT HAPTEN/

      The Journal of nuclear medicine
    21. GAUTHEROT E; LEDOUSSAL JM; BOUHOU J; MANETTI C; MARTIN M; ROUVIER E; BARBET J
      DELIVERY OF THERAPEUTIC DOSES OF RADIOIODINE USING BISPECIFIC ANTIBODY-TARGETED BIVALENT HAPTENS

      The Journal of nuclear medicine
    22. SERRE K; MACHY P; GRIVEL JC; JOLLY G; BRUN N; BARBET J; LESERMAN L
      EFFICIENT PRESENTATION OF MULTIVALENT ANTIGENS TARGETED TO VARIOUS CELL-SURFACE MOLECULES OF DENDRITIC CELLS AND SURFACE IG OF ANTIGEN-SPECIFIC B-CELLS

      The Journal of immunology (1950)
    23. JANEVIKIVANOVSKA E; GAUTHEROT E; DEBOISFERON MH; COHEN M; MILHAUD G; TARTAR A; ROSTENE W; BARBET J; GRUAZGUYON A
      BIVALENT HAPTEN-BEARING PEPTIDES DESIGNED FOR I-131 PRETARGETED RADIOIMMUNOTHERAPY

      Bioconjugate chemistry
    24. ROUVIER E; GAUTHEROT E; MEYER P; BARBET J
      TARGETING MEDULLARY-THYROID CARCINOMAS WITH BISPECIFIC ANTIBODIES ANDBIVALENT HAPTENS - RESULTS AND CLINICAL PERSPECTIVES

      Hormone research
    25. GAUTHEROT E; BOUHOU J; LOUCIF E; MANETTI C; MARTIN M; LEDOUSSAL JW; ROUVIER E; BARBET J
      RADIOIMMUNOTHERAPY OF LS174T COLON-CARCINOMA IN NUDE-MICE USING AN IODINE-131-LABELED BIVALENT HAPTEN COMBINED WITH AN ANTI-CEA X ANTI-INDIUM-DTPA BISPECIFIC ANTIBODY

      The Journal of nuclear medicine
    26. KRAEBERBODERE F; FAIVRECHAUVET A; SAIMAUREL C; LEBOTERFF J; GAUTHEROT E; BARBET J; CHATAL JF; THEDREZ P
      RADIOIMMUNOTHERAPY (RIT) WITH BISPECIFIC ANTIBODY AND I-131-LABELED BIVALENT HAPTEN IN NUDE-MICE BEARING A HUMAN MEDULLARY-THYROID CARCINOMA (MTC)

      The Journal of nuclear medicine
    27. VUILLEZ JP; MORO D; BRICHON PY; ROUVIER E; BRAMBILLA E; BARBET J; PELTIER P; MEYER P; SARRAZIN R; BRAMBILLA C
      2-STEP IMMUNOSCINTIGRAPHY FOR NON-SMALL-CELL LUNG-CANCER STAGING USING A BISPECIFIC ANTI-CEA ANTI-INDIUM-DTPA ANTIBODY AND AN INDIUM-111-LABELED DTPA DIMER/

      The Journal of nuclear medicine
    28. MANETTI C; ROUVIER E; GAUTHEROT E; LOUCIF E; BARBET J; LEDOUSSAL JM
      TARGETING BCL1 LYMPHOMA WITH ANTIIDIOTYPE ANTIBODIES - BIODISTRIBUTION KINETICS OF DIRECTLY LABELED ANTIBODIES AND BISPECIFIC ANTIBODY-TARGETED BIVALENT HAPTENS

      International journal of cancer
    29. GAUTHEROT E; BOUHOU J; LEDOUSSAL JM; MANETTI C; MARTIN M; ROUVIER E; BARBET J
      THERAPY FOR COLON-CARCINOMA XENOGRAFTS WITH BISPECIFIC ANTIBODY-TARGETED, IODINE-131-LABELED BIVALENT HAPTEN

      Cancer
    30. THIMONIER J; MONTIXI C; CHAUVIN JP; HE HT; ROCCASERRA J; BARBET J
      THY-1 IMMUNOLABELED THYMOCYTE MICRODOMAINS STUDIES WITH THE ATOMIC-FORCE MICROSCOPE AND THE ELECTRON-MICROSCOPE

      Biophysical journal
    31. MANETTI C; ROUVIER E; GAUTHEROT E; LOUCIF E; LEDOUSSAL JM; MARTIN M; BARBET J
      RADIOIMMUNOTHERAPY OF BCL1 LYMPHOMA WITH BISPECIFIC ANTIBODIES AND IODINE-131-LABELED BIVALENT HAPTENS

      The Journal of nuclear medicine
    32. BARDIES M; BARDET S; FAIVRECHAUVET A; PELTIER P; DOUILLARD JY; MAHE M; FICHE M; LISBONA A; GIACALONE F; MEYER P; GAUTHEROT E; ROUVIER E; BARBET J; CHATAL JF
      BISPECIFIC ANTIBODY AND IODINE-131-LABELED BIVALENT HAPTEN DOSIMETRY IN PATIENTS WITH MEDULLARY-THYROID OR SMALL-CELL LUNG-CANCER

      The Journal of nuclear medicine
    33. MARANINCHI D; BARBET J; BATTAIS J; EMILIE D; GOEHRS JM; GUINOT P; MANNONI P; MEYER P; ROMETLEMONNE JL; TROUVIN JH; CALVO F; GALANAUD P; GOUYETTE A; JULOU CL; MARCEL T; MOREL A; QUENTINMILLET MJ; SCHATZ C; WIJDENES J
      WHICH STATUS FOR DRUGS OF BIOLOGICAL ORIG IN

      Therapie
    34. DEVYS A; THEDREZ P; GAUTHEROT E; FAIVRECHAUVET A; SAIMAUREL C; ROUVIER E; AUGET JL; BARBET J; CHATAL JF
      COMPARATIVE TARGETING OF HUMAN COLON-CARCINOMA MULTICELL SPHEROIDS USING ONE-STEP AND 2-STEP (BISPECIFIC ANTIBODY) TECHNIQUES

      International journal of cancer
    35. BODEN V; COLIN C; BARBET J; LEDOUSSAL JM; VIJAYALAKSHMI M
      PRELIMINARY-STUDY OF THE METAL-BINDING SITE OF AN ANTI-DTPA-INDIUM ANTIBODY BY EQUILIBRIUM BINDING IMMUNOASSAYS AND IMMOBILIZED METAL-ION AFFINITY-CHROMATOGRAPHY

      Bioconjugate chemistry
    36. THIMONIER J; CHAUVIN JP; BARBET J; ROCCASERRA J
      PRELIMINARY STUDIES OF AN IMMUNOGLOBULIN-M BY NEAR-FIELD MICROSCOPIES

      Journal of trace and microprobe techniques
    37. CHATAL JF; FAIVRECHAUVET A; BARDIES M; PELTIER P; GAUTHEROT E; BARBET J
      BIFUNCTIONAL ANTIBODIES FOR RADIOIMMUNOTHERAPY

      Hybridoma
    38. JEAN F; BOURCIER B; LEBEC S; DELAAGE M; BARBET J
      A NOVEL PROTEIN IMMUNOASSAY WITH PREDETERMINED SPECIFICITY USING MONOCLONAL-ANTIBODIES AGAINST TRYPTIC FRAGMENTS - APPLICATION TO HIV P24 ANTIGEN

      Journal of immunological methods
    39. MANETTI C; LEDOUSSAL JM; ROUVIER E; GRUAZGUYON A; BARBET J
      INTRACELLULAR UPTAKE AND CATABOLISM OF ANTI-IGM ANTIBODIES AND BI-SPECIFIC ANTIBODY-TARGETED HAPTEN BY B-LYMPHOMA CELLS

      International journal of cancer
    40. MICHON J; MOUTEL S; BARBET J; ROMETLEMONNE JL; DEO YM; FRIDMAN WH; TEILLAUD JL
      IN-VITRO KILLING OF NEUROBLASTOMA-CELLS BY NEUTROPHILS DERIVED FROM GRANULOCYTE-COLONY-STIMULATING FACTOR-TREATED CANCER-PATIENTS USING AN ANTI-DISIALOGANGLIOSIDE ANTI-FC-GAMMA-RI BISPECIFIC ANTIBODY

      Blood
    41. THIMONIER J; CHAUVIN JP; BARBET J; ROCCASERRA J
      SCANNING-TUNNELING-MICROSCOPY OF MONOCLONAL IMMUNOGLOBULIN-G

      Microscopy microanalysis microstructures
    42. ROCCASERRA J; THIMONIER J; CHAUVIN JP; BARBET J
      SCANNING-TUNNELING-MICROSCOPY OF PROTEINS OF THE IMMUNOGLOBULIN SUPERFAMILY

      Journal of vacuum science & technology. B, Microelectronics and nanometer structures processing, measurement and phenomena
    43. PELTIER P; BARDET S; CHETANNEAU A; BARBET J; DELAAGE M; CHATAL JF
      SCINTIGRAPHIC IMAGING OF LIVER METASTASES (LM) USING BISPECIFIC ANTICARCINOEMBRYONIC ANTIGEN (CEA) ANTI-DTPA-INDIUM IMMUNOCONJUGATE AND DI-DTPA-IN-111/

      The Journal of nuclear medicine
    44. CHETANNEAU A; BARBET J; PELTIER P; BERNARD AM; LEDOUSSAL JM; GRUAZGUYON A; BOURGUET P; DELAAGE M; CHATAL JF
      IMAGING HUMAN COLORECTAL-CANCER RECURRENCE WITH IN-111-LABELED BIVALENT DTPA HAPTEN AND DUAL-SPECIFICITY MONOCLONAL-ANTIBODY CONJUGATE

      The Journal of nuclear medicine
    45. CHETANNEAU A; BARBET J; PELTIER P; LEDOUSSAL JM; GRUAZGUYON A; BERNARD AM; RESCHE I; ROUVIER E; BOURGUET P; DELAAGE M; CHATAL JF
      PRETARGETED IMAGING OF COLORECTAL-CANCER RECURRENCES USING AN IN-111-LABELED BIVALENT HAPTEN AND A BISPECIFIC ANTIBODY CONJUGATE

      Nuclear medicine communications
    46. BARBET J; GARVIN A; THIMONIER J; CHAUVIN JP; ROCCASERRA J
      SCANNING-TUNNELING-MICROSCOPY OF COLLOIDAL GOLD BEADS

      Ultramicroscopy
    47. PELTIER P; CURTET C; CHATAL JF; LEDOUSSAL JM; DANIEL G; AILLET G; GRUAZGUYON A; BARBET J; DELAAGE M
      RADIOIMMUNODETECTION OF MEDULLARY-THYROID CANCER USING A BISPECIFIC ANTI-CEA ANTI-INDIUM-DTPA ANTIBODY AND AN INDIUM-111-LABELED DTPA DIMER

      The Journal of nuclear medicine
    48. LEDOUSSAL JM; CHETANNEAU A; GRUAZGUYON A; MARTIN M; GAUTHEROT E; LEHUR PA; CHATAL JF; DELAAGE M; BARBET J
      BISPECIFIC MONOCLONAL ANTIBODY-MEDIATED TARGETING OF AN INDIUM-111-LABELED DTPA DIMER TO PRIMARY COLORECTAL TUMORS - PHARMACOKINETICS, BIODISTRIBUTION, SCINTIGRAPHY AND IMMUNE-RESPONSE

      The Journal of nuclear medicine
    49. BARBET J; LEDOUSSAL JM; GRUAZGUYON A; MARTIN M; GAUTHEROT E; DELAAGE M
      COMPUTER CALCULATION OF MULTIPLE BINDING EQUILIBRIUM ISOTHERMS - APPLICATION TO THE BINDING OF BIVALENT LIGANDS TO ANTIBODIES INTERACTING WITH CELL-SURFACE FC-RECEPTORS

      Journal of theoretical biology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 28/01/21 alle ore 08:00:29